IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 217 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,715,969 | +52.0% | 280,846 | +59.0% | 0.05% | +46.9% |
| Q4 2022 | $1,128,640 | +332.4% | 176,626 | +1193.3% | 0.03% | +100.0% |
| Q4 2021 | $261,000 | -55.2% | 13,657 | -42.3% | 0.02% | -65.2% |
| Q3 2021 | $583,000 | -47.0% | 23,652 | -32.0% | 0.05% | -54.5% |
| Q1 2021 | $1,100,000 | +99.6% | 34,757 | +107.7% | 0.10% | +188.6% |
| Q3 2020 | $551,000 | -58.1% | 16,733 | -65.0% | 0.04% | -61.5% |
| Q2 2020 | $1,314,000 | +150.8% | 47,870 | -13.1% | 0.09% | +145.9% |
| Q1 2019 | $524,000 | +88.5% | 55,079 | +122.7% | 0.04% | +76.2% |
| Q3 2018 | $278,000 | +115.5% | 24,732 | +144.5% | 0.02% | +133.3% |
| Q2 2018 | $129,000 | +4.0% | 10,114 | -34.6% | 0.01% | -35.7% |
| Q4 2017 | $124,000 | -59.6% | 15,464 | -60.9% | 0.01% | -81.8% |
| Q3 2017 | $307,000 | – | 39,590 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 11,826,299 | $130,562,000 | 4.09% |
| MPM BioImpact LLC | 1,200,000 | $13,248,000 | 3.68% |
| Finepoint Capital LP | 960,200 | $10,601,000 | 3.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,011 | $273,000,000 | 2.85% |
| Avoro Capital Advisors LLC | 9,220,000 | $101,789,000 | 2.01% |
| Long Focus Capital Management, LLC | 1,625,000 | $17,940,000 | 1.88% |
| 683 Capital Management, LLC | 2,000,000 | $22,080,000 | 1.56% |
| Parametrica Management Ltd | 115,870 | $1,268,000 | 1.38% |
| Boxer Capital, LLC | 1,935,133 | $21,364,000 | 1.35% |
| Soleus Capital Management, L.P. | 719,600 | $7,944,000 | 1.24% |